Trial Profile
Single-center experience with first-line S-1 plus cisplatin chemotherapy for locally advanced unresectable and metastatic gastric and gastroesophageal junction adenocarcinoma in a Caucasian population
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Oct 2015
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- 07 Oct 2015 New trial record